SanBio is a developer and provider of neural regenerative medicines. Products offered include: SB308, which treats muscular dystrophy and trauma; SB623, which treats Parkinson's, strokes and injured spinal cords; and SB618, which treats spinal cord injuries and multiple sclerosis. Visit SanBio's website for more information on the company, products, innovative technologies developed by the company and information on potential employment opportunities.